The use of transcatheter aortic valve replacement (TAVR) has been increasing in all age brackets, and the ratio of TAVR to surgical aortic valve replacement (SAVR) has also increased [ ]. While considered less invasive, TAVRs have their own adverse events and complications including vascular damage, gastrointestinal bleeding, and even neurologic or genitourinary bleeding [ ]. Moreover, patients undergoing TAVR may require blood transfusion to maintain hemodynamic stability [ ].